Table S1. Location and type of lung lesions.
Variables | COVID-19 (n=1,207 lesions) | Lung cancer (n=448 lesions) | P value |
---|---|---|---|
Location of lesions, n (% of all lesions) | 0.014* | ||
Peripheral | 923 (76%) | 333 (74%) | 0.40 |
Central | 55 (5%) | 29 (6%) | 0.15 |
Both | 209 (17%) | 86 (19%) | 0.42 |
Unknown | 20 (2%) | 0 (0%) | 0.013 |
Type of lesions, n (% of all lesions) | <0.0001* | ||
Pure GGO | 321(27%) | 204 (46%) | <0.0001 |
Mixed GGO | 695 (58%) | 210 (47%) | 0.00013 |
Consolidation | 170 (14%) | 24 (5%) | <0.0001 |
Unknown | 21 (2%) | 10 (2%) | 0.65 |
*, Pearson’s chi-squared test for overall distribution. GGO, ground-glass opacity.